Data / Form D filings / Molecular Templates, Inc.
Molecular Templates, Inc.: Form D filings
Molecular Templates, Inc., a biotechnology company in Austin, TX, filed 6 Form D notices with the SEC between 2009 and 2023. The latest, on July 31, 2023, reports $20 million sold of a $90.7 million offering to 19 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 9301 Amberglen Blvd, Suite 100, Austin, TX, 78729
- Phone
- (512) 869-1555
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1183765
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 31, 2023 | New notice | $90,738,000 | $19,999,998 | $70,738,002 | 19 | Jul 17, 2023 | sec.gov |
| Dec 3, 2019 | Amendment | $14,999,994 | $14,999,994 | 1 | Nov 18, 2019 | sec.gov | |
| Nov 27, 2019 | New notice | $14,999,994 | $14,999,994 | 1 | Nov 18, 2019 | sec.gov | |
| Aug 15, 2017 | New notice | $20,000,000 | $20,000,000 | 1 | Aug 1, 2017 | sec.gov | |
| Aug 15, 2017 | New notice | $40,000,000 | $40,000,000 | 16 | Aug 1, 2017 | sec.gov | |
| Oct 15, 2009 | New notice | $35,000,000 | $35,000,000 | 47 | Oct 5, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jason E. Kim | Executive Officer | |
| Eric E. Poma | Executive Officer, Director | |
| David E. Hoffmann | Director | |
| Roger J. Waltzman | Executive Officer | |
| Jonathan E. Lanfear | Director | |
| Kevin E. Lalande | Director | |
| Corsee E. Sanders | Director | |
| Harold E. Selick | Director | |
| Gabriela E. Gruia | Director |
Other biotechnology companies in Texas that filed recently
- Nuclein, LLC $15.7 million · Oct 27, 2026
- OncoNano Medicine, Inc. $10.1 million · Oct 8, 2026
- Solaris Endovascular Inc. $5 million · Oct 1, 2026
- Hera Biotech, Inc. $1.7 million · Sep 23, 2026
- Kayak Therapeutics, Inc. $25 million · Aug 21, 2026
- InnovoTEX Inc. $2.7 million · Aug 18, 2026
Every Form D from the week of Jul 31, 2023 · All recent filings in Texas · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Molecular Templates, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.